Explained: Philips Respironics’ testing program - CPAP and BiPAP sleep therapy devices

In June 2021, Philips initiated a voluntary recall notification / field safety notice for certain CPAP and BiPAP sleep therapy devices and mechanical ventilators to address potential health risks related to the polyester-based polyurethane (PE-PUR) sound abatement foam that was used in these devices until June 2021. Since then, together with five independent, certified testing laboratories and third-party experts, Philips Respironics has conducted extensive testing. Based on the results to date, Philips Respironics and the third-party experts concluded that use of the sleep therapy devices is not expected to result in appreciable harm to health in patients. In this short video, Jan Bennik, Head of Test and Research Program, explains what these devices are used for, why and how much PE-PUR foam was used in these devices, and what the extensive testing program found.